We provide the first evidence that the TAPSE/sPAP ratio, both when used alone and in combination with NT-proANP plasma level, appears the most suitable parameter for the clinical and prognostic assessment of SSc patients. The gene discussed is PDZK1IP1; the disease is systemic sclerosis.